Moretus Research initiated coverage of Archer-Daniels-Midland (ADM) with a Buy rating and a $66 price target, citing margin recovery driven by self-help cost-out initiatives and operational leverage as key catalysts for an earnings rebound into 2026. The report suggests that ADM's dividend durability and capital returns are underappreciated, providing shareholder value despite cyclical and legal uncertainties, and recommends accumulating the stock in anticipation of earnings normalization and policy tailwinds.
Moretus Research has initiated coverage on Archer-Daniels-Midland (ADM) with a 'Buy' rating and a $66 price target, projecting a compelling earnings rebound extending into 2026. This optimistic outlook is primarily driven by anticipated margin recovery, supported by aggressive self-help cost-out initiatives and operational leverage, which are expected to offset near-term margin and insurance-related headwinds. The research highlights that ADM's dividend durability and capital return programs are currently underappreciated by the market, offering a significant shareholder cushion amidst cyclical and legal uncertainties. Moretus Research posits that while ADM's current valuation reflects these near-term risks, the market misprices the company's forward leverage, suggesting an opportunity for accumulation ahead of expected earnings normalization and potential policy tailwinds.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment